← all drugs
Sodium Acetate Injection
in shortage · Endocrinology/Metabolism · Snapshot: 2026-10-09
Day 3,901
of this shortage, counting from the FDA's first posting on 02/03/2016
- Manufacturers listed
- Milla Pharmaceuticals, Hikma Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC, Hospira, Inc., a Pfizer Company, Somerset Therapeutics, LLC
- Reported reason(s)
- Other
- Machine-readable
- JSON for this drug
Presentations (15)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) | Milla Pharmaceuticals | Limited Availability | 10/01/2026 |
| Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) | Milla Pharmaceuticals | Available | 10/01/2026 |
| Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00) | Fresenius Kabi USA, LLC | Available | 09/15/2026 |
| Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06) | Hospira, Inc., a Pfizer Company | Limited Availability | 08/24/2026 |
| Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20) | Somerset Therapeutics, LLC | Available | 09/11/2026 |
| Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) | Milla Pharmaceuticals | Available | 10/01/2026 |
| Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25) | Somerset Therapeutics, LLC | Available | 09/11/2026 |
| Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) | Milla Pharmaceuticals | Available | 10/01/2026 |
| Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.